Research
My research asks where inequalities in mental health arise: the points at which someone’s needs are noticed or missed by services, and acted on or not. Whether a school recognises a child’s autism, whether someone with a drug problem and a mental illness reaches treatment, and what support a person with severe mental illness receives outside hospital can all shape what follows, and each differs between groups and places.
Many people’s needs span more than one service: schools and the NHS, mental health and addiction treatment, health and social care. Each service sees and records only its part, so these points are often invisible in any single dataset. I use records from schools, the NHS, and addiction treatment services, linked where possible, to find where inequalities arise, so that services and policy can act on them. In this sense the work extends the “pathways to care” tradition in psychiatric epidemiology beyond health services. How such records can be used well, and in ways the public can trust, is described under How I work.
I follow this question in three areas, each developed through a series of studies. Funding details are on the Funding page, and the full record is on Publications.
School and health
Autistic and other neurodivergent children are identified, supported, and excluded from school at different rates depending on who they are and where they live. Much of what happens to them is recorded in education data, and much in health data.
- Autism incidence in English schools. With colleagues at the University of Cambridge, we studied recorded autism among more than 7 million pupils in English state schools and found that incidence differed sharply between social and ethnic groups and between areas (Lancet Child & Adolescent Health, 2022). I was joint first author and led the population and spatial analyses. A 2026 OECD report on rising childhood autism diagnoses cites the study as evidence of under-diagnosis among girls from minority ethnic groups.
- HOPE-SEN (2024 to 2026). My ADR UK fellowship built on that study. It used linked national education and hospital records (ECHILD) to examine school absence, exclusion, alternative provision, and hospital admission among pupils receiving support for neurodevelopmental needs. Three first author papers are in preparation, and the analysis code is openly archived.
- Policy and doctoral research. With Vanessa Cieplinska, a PhD student I co-supervise, and Professor Vasiliki Totsika, I submitted written evidence to the House of Commons Education Committee on persistent school absence among autistic pupils and pupils with intellectual disability (2026).
Mental health and addiction services
People with drug or alcohol problems often have mental health needs too, and the two are usually treated by different services. I study who reaches treatment and what stands in the way.
- Access to treatment. My doctoral research used national US data to show inequalities in unmet need for mental health treatment (International Journal for Equity in Health, 2019) and in the provision of opioid agonist treatment by area, organisation, and payment (PLOS ONE, 2020); I was first author of both. In a London cohort, I contributed to a study showing that people with opioid use disorder and co-occurring mental health diagnoses had earlier and more frequent contact with crisis and inpatient services (Substance Abuse Treatment, Prevention, and Policy, 2023).
- UNITED (2026). I am the named lead investigator of this NIHR Team Science award, which brings together researchers, the national treatment providers Change Grow Live and Turning Point, and lived experience researchers. It asks what England’s National Drug Treatment Monitoring System can show about who reaches treatment. I led its scoping review of 83 research outputs that use these data (preprint, under review) and its work on principles for using them responsibly. Findings, outputs, and a recorded Lunch and Learn with the NIHR Public Health Policy Research Unit are on the project website.
- Stigma in services (2026). I lead the quantitative evaluation of a co-produced course for health and care staff who work with people who use drugs, funded through the NIHR School for Public Health Research.
- I am an Associate Editor of Addiction.
Health and social care in severe mental illness
People with severe mental illness are supported in hospital, in the community, and by social care, and what happens to them in one setting shapes the others. I study treatment, harms, and inequalities in severe mental illness, including the support recorded outside the NHS.
- Medication harms. Among 13,391 patients of a London mental health service, antipsychotic polypharmacy was associated with endocrine and metabolic adverse drug reactions recorded in routine care (Psychological Medicine, 2022). I was joint first author and led the analysis and writing.
- WISDOM (2026 to 2029). My UKRI Mental Health Platform Cross-Hub Fellowship brings together the Complex Emotions, DATAMIND, and Social Health hubs to study the social, emotional, environmental, and institutional drivers of severe and enduring mental illness.
- Observation on psychiatric wards (2024 to 2027). In this £1.5 million NIHR study led by Professor Alexandra Pitman, I lead the electronic health record work package, which uses natural language processing to identify enhanced patient observation in clinical notes.
- Linking health and social care data (from 2027). I co-lead a work package on the acceptability and governance of linking health and social care records in a new NIHR School for Social Care Research study led by Professor Peter Bath.
How I work
Seeing where needs are recognised or missed depends on records that are well governed, linked, and documented, and used in ways the public can trust. I work on this directly.
- NHS research database. Since 2019 I have helped run the research database of what is now North London NHS Foundation Trust, first as Database Manager and now as Deputy Lead. After the merger of Camden and Islington and Barnet, Enfield and Haringey mental health trusts, I led the integration of their records into a single research database, including the ethics and Confidentiality Advisory Group approvals and new access arrangements. I have advised on 31 research projects using the database and contribute to harmonisation with the equivalent databases at South London and Maudsley, Oxford Health, and Cambridgeshire and Peterborough.
- National data governance. I am an Expert Member of the Health Research Authority’s Confidentiality Advisory Group, which advises on when confidential patient information can be used without consent. I am also a public member of the Eastern England Secure Data Environment’s Data Access Committee and a member of an ADR UK Task and Finish Group on researchers’ access to data.
- Public involvement. With colleagues, I co-led an HDR UK and DARE UK project embedding national public involvement standards in the research database’s governance.
Methods
I work mainly with linked national administrative data in trusted research environments; electronic health records and natural language processing of clinical text, including large language models used within governed environments; longitudinal, multilevel, and spatial models; and causal inference for observational data. As senior author, I also designed an audit of how alcohol research collects and reports data on sexual orientation and gender identity (LGBT Health, 2024), which our team has since applied to cardiovascular research.
Where data cannot be shared, I release analysis code and teaching materials, including workshop materials on good practice in R for researchers using the ONS Secure Research Service; see Code and resources.